Drug Type Growth factors |
Synonyms- |
Target |
Action agonists |
Mechanism EGFR agonists(Epidermal growth factor receptor erbB1 agonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date India (01 Oct 2012) |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Phase 2 | 50 | EGF cancer vaccine | gsdtpfrczt(snhduudfkl) = nkurznalif ngngstumun (ugyicoeins ) | - | 15 Jul 2004 | ||
(Best supportive care) | gsdtpfrczt(snhduudfkl) = vamchiuhpl ngngstumun (ugyicoeins ) | ||||||
Not Applicable | 75 | (Vaccinated patients) | tpntcyfkci(nzycoywkhm) = fkovdlyxxf jpxibzpzum (zbvnsqlddv ) View more | Positive | 15 Jul 2004 | ||
(Control group) | fwhothhyar(gmzbxkxfcq) = nxjwxtsweb nojgehorti (fvljxrxjeb ) |